A citation-based method for searching scientific literature

Paola Toniati, Simone Piva, Marco Cattalini, Emirena Garrafa, Francesca Regola, Francesco Castelli, Franco Franceschini, Paolo Airò, Chiara Bazzani, Eva-Andrea Beindorf, Marialma Berlendis, Michela Bezzi, Nicola Bossini, Maurizio Castellano, Sergio Cattaneo, Ilaria Cavazzana, Giovanni-Battista Contessi, Massimo Crippa, Andrea Delbarba, Elena De Peri, Angela Faletti, Matteo Filippini, Matteo Filippini, Micol Frassi, Mario Gaggiotti, Roberto Gorla, Michael Lanspa, Silvia Lorenzotti, Rosa Marino, Roberto Maroldi, Marco Metra, Alberto Matteelli, Denise Modina, Giovanni Moioli, Giovanni Montani, Maria-Lorenza Muiesan, Silvia Odolini, Elena Peli, Silvia Pesenti, Maria-Chiara Pezzoli, Ilenia Pirola, Alessandro Pozzi, Alessandro Proto, Francesco-Antonio Rasulo, Giulia Renisi, Chiara Ricci, Damiano Rizzoni, Giuseppe Romanelli, Mara Rossi, Massimo Salvetti, Francesco Scolari, Liana Signorini, Marco Taglietti, Gabriele Tomasoni, Lina-Rachele Tomasoni, Fabio Turla, Alberto Valsecchi, Davide Zani, Francesco Zuccalà, Fiammetta Zunica, Emanuele Focà, Laura Andreoli, Nicola Latronico. Autoimmun Rev 2020
Times Cited: 468







List of co-cited articles
702 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effective treatment of severe COVID-19 patients with tocilizumab.
Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, Yonggang Zhou, Xiaohu Zheng, Yun Yang, Xiuyong Li,[...]. Proc Natl Acad Sci U S A 2020
34

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu,[...]. Lancet 2020
32

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
29

COVID-19: consider cytokine storm syndromes and immunosuppression.
Puja Mehta, Daniel F McAuley, Michael Brown, Emilie Sanchez, Rachel S Tattersall, Jessica J Manson. Lancet 2020
28

Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, Jovana Milic, Roberto Tonelli, Marianna Menozzi, Erica Franceschini, Gianluca Cuomo, Gabriella Orlando, Vanni Borghi,[...]. Lancet Rheumatol 2020
559
27

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Emanuel Della-Torre, Marco Ripa, Diana Canetti, Chiara Oltolini, Barbara Castiglioni, Chiara Tassan Din, Nicola Boffini,[...]. Lancet Rheumatol 2020
565
24

Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan R Emberson, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Christopher Brightling, Andrew Ustianowski, Einas Elmahi,[...]. N Engl J Med 2021
24

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
Chaomin Wu, Xiaoyan Chen, Yanping Cai, Jia'an Xia, Xing Zhou, Sha Xu, Hanping Huang, Li Zhang, Xia Zhou, Chunling Du,[...]. JAMA Intern Med 2020
23

Tocilizumab treatment in COVID-19: A single center experience.
Pan Luo, Yi Liu, Lin Qiu, Xiulan Liu, Dong Liu, Juan Li. J Med Virol 2020
725
19

Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline,[...]. N Engl J Med 2020
19

Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi. Eur J Intern Med 2020
167
18

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
Corrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, Giacomo De Luca, Marco Ripa, Nicola Boffini, Alessandro Tomelleri, Elena Baldissera, Patrizia Rovere-Querini, Annalisa Ruggeri,[...]. Eur J Intern Med 2020
240
17

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
Savino Sciascia, Franco Aprà, Alessandra Baffa, Simone Baldovino, Daniela Boaro, Roberto Boero, Stefano Bonora, Andrea Calcagno, Irene Cecchi, Giacoma Cinnirella,[...]. Clin Exp Rheumatol 2020
188
16

Anakinra for severe forms of COVID-19: a cohort study.
Thomas Huet, Hélène Beaussier, Olivier Voisin, Stéphane Jouveshomme, Gaëlle Dauriat, Isabelle Lazareth, Emmanuelle Sacco, Jean-Marc Naccache, Yvonnick Bézie, Sophie Laplanche,[...]. Lancet Rheumatol 2020
344
16

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
John H Stone, Matthew J Frigault, Naomi J Serling-Boyd, Ana D Fernandes, Liam Harvey, Andrea S Foulkes, Nora K Horick, Brian C Healy, Ruta Shah, Ana Maria Bensaci,[...]. N Engl J Med 2020
684
16


Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-Jie Guan, Zheng-Yi Ni, Yu Hu, Wen-Hua Liang, Chun-Quan Ou, Jian-Xing He, Lei Liu, Hong Shan, Chun-Liang Lei, David S C Hui,[...]. N Engl J Med 2020
15

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
14

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang,[...]. Clin Infect Dis 2020
13

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
T Klopfenstein, S Zayet, A Lohse, J-C Balblanc, J Badie, P-Y Royer, L Toko, C Mezher, N J Kadiane-Oussou, M Bossert,[...]. Med Mal Infect 2020
153
13

Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE).
Marta Colaneri, Laura Bogliolo, Pietro Valsecchi, Paolo Sacchi, Valentina Zuccaro, Fabio Brandolino, Carlomaurizio Montecucco, Francesco Mojoli, Emanuele Maria Giusti, Raffaele Bruno,[...]. Microorganisms 2020
134
13

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.
Valentina Morena, Laura Milazzo, Letizia Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Bassoli, Alessandro Torre, Maria Vittoria Cossu, Caterina Minari, Elisabetta Ballone,[...]. Eur J Intern Med 2020
116
13

COVID-19: combining antiviral and anti-inflammatory treatments.
Justin Stebbing, Anne Phelan, Ivan Griffin, Catherine Tucker, Olly Oechsle, Dan Smith, Peter Richardson. Lancet Infect Dis 2020
575
12

Clinical and immunological features of severe and moderate coronavirus disease 2019.
Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, Tao Wang, Xiaoyun Zhang, Huilong Chen, Haijing Yu,[...]. J Clin Invest 2020
12

Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L Green, François-Xavier Lescure,[...]. N Engl J Med 2020
12

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood. Autoimmun Rev 2020
823
11

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Safiya Richardson, Jamie S Hirsch, Mangala Narasimhan, James M Crawford, Thomas McGinn, Karina W Davidson, Douglas P Barnaby, Lance B Becker, John D Chelico, Stuart L Cohen,[...]. JAMA 2020
11

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu,[...]. Lancet 2020
11

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Dawei Wang, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, Hui Xiang, Zhenshun Cheng, Yong Xiong,[...]. JAMA 2020
11

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei,[...]. Lancet 2020
11

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
Christina C Price, Frederick L Altice, Yu Shyr, Alan Koff, Lauren Pischel, George Goshua, Marwan M Azar, Dayna Mcmanus, Sheau-Chiann Chen, Shana E Gleeson,[...]. Chest 2020
111
11

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
11

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Xiaobo Yang, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang,[...]. Lancet Respir Med 2020
11

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
F A Klok, M J H A Kruip, N J M van der Meer, M S Arbous, D A M P J Gommers, K M Kant, F H J Kaptein, J van Paassen, M A M Stals, M V Huisman,[...]. Thromb Res 2020
10

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
Evangelos J Giamarellos-Bourboulis, Mihai G Netea, Nikoletta Rovina, Karolina Akinosoglou, Anastasia Antoniadou, Nikolaos Antonakos, Georgia Damoraki, Theologia Gkavogianni, Maria-Evangelia Adami, Paraskevi Katsaounou,[...]. Cell Host Microbe 2020
10

Tocilizumab for the treatment of severe coronavirus disease 2019.
Rand Alattar, Tawheeda B H Ibrahim, Shahd H Shaar, Shiema Abdalla, Kinda Shukri, Joanne N Daghfal, Mohamed Y Khatib, Mohamed Aboukamar, Mohamed Abukhattab, Hussam A Alsoub,[...]. J Med Virol 2020
155
10

Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study.
Tariq Kewan, Fahrettin Covut, Mohammed J Al-Jaghbeer, Lori Rose, K V Gopalakrishna, Bassel Akbik. EClinicalMedicine 2020
101
10

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
Maximilian Ackermann, Stijn E Verleden, Mark Kuehnel, Axel Haverich, Tobias Welte, Florian Laenger, Arno Vanstapel, Christopher Werlein, Helge Stark, Alexandar Tzankov,[...]. N Engl J Med 2020
10

Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu,[...]. Lancet Respir Med 2020
10

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.
Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, Jonathan L Golob, Tejal N Gandhi, Lu Wang, Nina Zhou, Lindsay A Petty, Ji Hoon Baang, Nicholas O Dillman,[...]. Clin Infect Dis 2021
232
10

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira,[...]. Int J Antimicrob Agents 2020
10

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
Peter Richardson, Ivan Griffin, Catherine Tucker, Dan Smith, Olly Oechsle, Anne Phelan, Michael Rawling, Edward Savory, Justin Stebbing. Lancet 2020
729
9

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.
Fabrizio Cantini, Laura Niccoli, Daniela Matarrese, Emanuele Nicastri, Paolo Stobbione, Delia Goletti. J Infect 2020
252
9



Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
Anthony C Gordon, Paul R Mouncey, Farah Al-Beidh, Kathryn M Rowan, Alistair D Nichol, Yaseen M Arabi, Djillali Annane, Abi Beane, Wilma van Bentum-Puijk, Lindsay R Berry,[...]. N Engl J Med 2021
594
9


Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Qiurong Ruan, Kun Yang, Wenxia Wang, Lingyu Jiang, Jianxin Song. Intensive Care Med 2020
8

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
8

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, Yuk-Yung Ng, Jenny Lo, Jacky Chan, Anthony Raymond Tam,[...]. Lancet 2020
829
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.